Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies Post author:Sam Post published:December 13, 2017 Post category:BioPharma Investors were Atlas Venture and OrbiMed. Source: BioSpace You Might Also Like What You Need to Know About Boragen January 9, 2018 Acadia Reports First Quarter 2017 Financial Results May 9, 2017 Why a Buyout Deal May Not Be in the Cards for Acadia November 27, 2017
